These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6343310)

  • 21. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
    Ionescu V
    Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862
    [No Abstract]   [Full Text] [Related]  

  • 22. Survival in chronic granulocytic leukemia. Splenic irradiation vs busulfan.
    Conrad FG
    Arch Intern Med; 1973 May; 131(5):684-5. PubMed ID: 4512787
    [No Abstract]   [Full Text] [Related]  

  • 23. Splenic irradiation in chronic myeloid leukemia.
    Hukku S; Baboo HA; Venkataratnam S; Vidyasagar MS; Patel NL
    Acta Radiol Oncol; 1983; 22(1):9-12. PubMed ID: 6305140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Varying course of pancytopenia after busulfan treatment of chronic myelocytic leukemia (CML)].
    Krug K; Stenzel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):181-7. PubMed ID: 79522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenic irradiation in the management of chronic granulocytic leukaemia.
    Jacobs P; Dubovsky D; King H; Sealy R
    Cent Afr J Med; 1975 Oct; 21(10):207-10. PubMed ID: 1059505
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
    Sullivan JR; Hurley TH; Bolton JH
    Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Busulfan-induced sideroblastic anemia.
    Fernandez LA; Zayed E
    Am J Hematol; 1988 Jul; 28(3):199-200. PubMed ID: 3165601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.
    Gollerkeri MP; Shah GB
    Cancer; 1971 Mar; 27(3):596-601. PubMed ID: 5279330
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.
    Sakellari I; Gavriilaki E; Chatziioannou K; Papathanasiou M; Mallouri D; Batsis I; Bousiou Z; Bouziana S; Constantinou V; Douka V; Apostolou C; Iskas M; Lalayanni C; Athanasiadou A; Sotiropoulos D; Yannaki E; Gianouzakos V; Anagnostopoulos A
    Ann Hematol; 2018 Oct; 97(10):1987-1994. PubMed ID: 29869673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.
    Lynch MH; Petersen FB; Appelbaum FR; Bensinger WI; Clift RA; Storb R; Sanders JE; Hansen JA; Buckner CD
    Bone Marrow Transplant; 1995 Jan; 15(1):59-64. PubMed ID: 7742756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia.
    Br Med J; 1968 Jan; 1(5586):201-8. PubMed ID: 5235190
    [No Abstract]   [Full Text] [Related]  

  • 32. Busulfan, antimetabolites, radiotherapy, and cost of treatment in chronic myelocytic leukemia. A non-controlled, non-randomized monocenter study with historical controls.
    Ogier C; Reizenstein P
    Acta Med Scand; 1981; 210(5):409-13. PubMed ID: 6950660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
    Fu H; Xu L; Liu D; Liu K; Zhang X; Chen H; Chen Y; Han W; Wang Y; Wang J; Wang F; Huang X
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1176-82. PubMed ID: 24747336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
    Petersen FB; Buckner CD; Appelbaum FR; Clift RA; Sanders JE; Bensinger WI; Storb R; Witherspoon RP; Sullivan KM; Bearman SI
    Bone Marrow Transplant; 1989 Nov; 4(6):617-23. PubMed ID: 2684307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 36. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
    Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
    J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observations on the therapy of chronic granulocytic leukaemia (C.G.L.) in adults.
    Das KV; Thomas M; Pilla MV; Vijayakumar
    J Assoc Physicians India; 1977 Aug; 25(8):547-53. PubMed ID: 275251
    [No Abstract]   [Full Text] [Related]  

  • 38. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
    Spitzer TR; Cottler-Fox M; Torrisi J; Cahill R; Greenspan A; Lynch M; Deeg HJ
    Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
    Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
    Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The busulfan therapy of chronic granulocytic leukemia].
    Kinugasa K; Takaku F; Sassa S; Chiba S; Mizoguchi H
    Nihon Naika Gakkai Zasshi; 1969 Nov; 58(11):1191-6. PubMed ID: 5261216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.